FCFS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient buyer: earnings are scheduled for 2026-02-05 pre-market, and options pricing shows elevated implied volatility, meaning the market is braced for a potentially sharp move.", "The trend is bullish and fundamentals are improving, but the risk/reward immediately ahead of earnings is unfavorable versus waiting for the post-earnings direction/confirmation.", "Insider activity is a key negative: insiders are selling and the selling amount increased 386.71% over the last month."]
["Trend: Bullish structure with moving averages stacked positively (SMA_5 > SMA_20 > SMA_200), consistent with an ongoing uptrend.", "Momentum: MACD histogram is positive (0.0224) and expanding, supporting continued upside momentum.", "RSI: RSI_6 at ~63 is neutral-to-bullish (not overbought), implying room for continuation but also near-term cooling risk.", "Levels: Pivot support near 169.718; downside support S1 ~165.999. Immediate resistance R1 ~173.436 then R2 ~175.734. With price ~171.9, it\u2019s closer to resistance than support, reducing immediate upside-to-downside skew.", "Intellectia Proprietary Trading Signals", "- AI Stock Picker: No signal on given stock today.", "- SwingMax: No signal on given stock recently."]
["Upcoming catalyst: QDEC 2025 earnings on 2026-02-05 pre-market (event can unlock upside if results/guidance beat).", "Price action/technicals are constructive (bullish MA stack + positive MACD).", "Pattern-based projection shows a favorable 1-month skew (+14.63% over the next month in the similar-pattern cohort)."]
["Insiders are selling, and selling activity accelerated sharply (+386.71% over the last month).", "Earnings event is immediate; elevated IV indicates the market expects a sizable move, increasing the chance of an unfavorable gap for a new entry today.", "Near-term statistical edge is not supportive: similar-pattern cohort suggests -0.17% next day and -1.54% next week."]
["Latest quarter provided: 2025/Q3 showed solid acceleration.", "Revenue: 853.9M, +10.02% YoY (healthy top-line growth).", "Net income: 82.8M, +27.74% YoY (profit growth outpacing revenue).", "EPS: 1.86, +29.17% YoY (strong per-share earnings momentum).", "Gross margin: 42.51%, +3.91% YoY (margin expansion supports quality of growth)."]
["No analyst rating/price target change data was provided, so a recent trend summary cannot be confirmed from the dataset.", "Wall Street-style pros (based on provided fundamentals/technicals): accelerating earnings and margin expansion; bullish technical posture.", "Wall Street-style cons (based on provided positioning/flows): heavy insider selling; earnings-driven uncertainty priced into options (high IV), which can punish new buyers on a miss or cautious guidance.", "Politicians/congress: No recent congress trading data available; no politician/influential-figure trades were provided."]
